1. Home
  2. DIN vs EBS Comparison

DIN vs EBS Comparison

Compare DIN & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dine Brands Global Inc.

DIN

Dine Brands Global Inc.

HOLD

Current Price

$28.10

Market Cap

446.6M

ML Signal

HOLD

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

HOLD

Current Price

$8.02

Market Cap

434.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIN
EBS
Founded
1958
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
446.6M
434.4M
IPO Year
1994
2006

Fundamental Metrics

Financial Performance
Metric
DIN
EBS
Price
$28.10
$8.02
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$29.67
$12.00
AVG Volume (30 Days)
380.5K
983.7K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
2.69%
N/A
EPS Growth
N/A
125.83
EPS
1.11
0.93
Revenue
$879,300,000.00
$742,900,000.00
Revenue This Year
$3.61
$29.50
Revenue Next Year
$0.41
N/A
P/E Ratio
$25.40
$8.61
Revenue Growth
8.25
N/A
52 Week Low
$18.63
$4.02
52 Week High
$39.68
$14.06

Technical Indicators

Market Signals
Indicator
DIN
EBS
Relative Strength Index (RSI) 35.69 30.26
Support Level $27.52 $7.66
Resistance Level $28.64 $9.47
Average True Range (ATR) 1.18 0.50
MACD -0.17 -0.02
Stochastic Oscillator 13.71 11.36

Price Performance

Historical Comparison
DIN
EBS

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: